C

Cryo-Cell International Inc
AMEX:CCEL

Watchlist Manager
Cryo-Cell International Inc
AMEX:CCEL
Watchlist
Price: 8.35 USD 0.6% Market Closed
Market Cap: 67.3m USD
Have any thoughts about
Cryo-Cell International Inc?
Write Note

Cryo-Cell International Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cryo-Cell International Inc
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
C
Cryo-Cell International Inc
AMEX:CCEL
Additional Paid In Capital
$44m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
5%
DaVita Inc
NYSE:DVA
Additional Paid In Capital
$295.6m
CAGR 3-Years
-17%
CAGR 5-Years
-20%
CAGR 10-Years
-12%
Quest Diagnostics Inc
NYSE:DGX
Additional Paid In Capital
$2.3B
CAGR 3-Years
6%
CAGR 5-Years
-3%
CAGR 10-Years
0%
CVS Health Corp
NYSE:CVS
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Additional Paid In Capital
$31.2B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
25%
Laboratory Corporation of America Holdings
NYSE:LH
Additional Paid In Capital
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Cryo-Cell International Inc
Glance View

Market Cap
67.3m USD
Industry
Health Care

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.

CCEL Intrinsic Value
5.83 USD
Overvaluation 30%
Intrinsic Value
Price
C

See Also

What is Cryo-Cell International Inc's Additional Paid In Capital?
Additional Paid In Capital
44m USD

Based on the financial report for Aug 31, 2024, Cryo-Cell International Inc's Additional Paid In Capital amounts to 44m USD.

What is Cryo-Cell International Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
5%

Over the last year, the Additional Paid In Capital growth was 2%. The average annual Additional Paid In Capital growth rates for Cryo-Cell International Inc have been 2% over the past three years , 4% over the past five years , and 5% over the past ten years .

Back to Top